(S,R,S)-AHPC-C4-NH2 is a high-purity E3 ligase ligand-linker conjugate specifically designed for use in PROTAC (Proteolysis Targeting Chimera) drug discovery and research. As a derivative of AHPC (an analog of VH032), this compound serves as a highly selective ligand for the von Hippel-Lindau (VHL) E3 ubiquitin ligase. The incorporated C4 aliphatic linker and terminal amine (NH2) group provide optimal versatility for chemical conjugation with target protein ligands, enabling the efficient construction of PROTACs. PROTACs are a groundbreaking technology that utilize small molecules to specifically induce the ubiquitination and proteasomal degradation of disease-related proteins, offering new therapeutic strategies for undruggable targets. (S,R,S)-AHPC-C4-NH2 is ideal for researchers developing next-generation targeted protein degraders and exploring novel therapeutic pathways in oncology, neurodegeneration, and other disease areas.
Structure of 2138439-53-7
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
(S,R,S)-AHPC-C4-NH2 is a specialized E3 ligase ligand-linker conjugate widely used in the development of PROTACs (Proteolysis Targeting Chimeras). It incorporates the highly selective AHPC ligand, which is designed to recruit the von Hippel-Lindau (VHL) E3 ubiquitin ligase, and features a C4 polyethylene glycol (PEG4) linker, terminated with an aminated group for convenient conjugation.
Mechanism
The mechanism of (S,R,S)-AHPC-C4-NH2 centers on targeted protein degradation harnessed by the PROTAC system. The AHPC motif specifically binds to the VHL E3 ubiquitin ligase, while the C4-NH2 linker is engineered to be chemically connected to a ligand targeting the protein of interest. When assembled into a complete PROTAC molecule, (S,R,S)-AHPC-C4-NH2 brings the target protein into proximity with the E3 ligase, triggering ubiquitination and subsequent proteasomal degradation, thus enabling the selective elimination of disease-relevant proteins.
Applications
(S,R,S)-AHPC-C4-NH2 is extensively applied in the design and synthesis of PROTAC molecules for targeted protein degradation in drug discovery. It serves as a versatile intermediate for creating bifunctional compounds that degrade cancer-associated, inflammatory, or pathogenic proteins. Researchers utilize it for rapid profiling of protein function, the development of chemical biology tools, and the advancement of next-generation therapeutics. Its high binding affinity and modular linker design make it ideal for generating custom PROTACs relevant to oncology, neuroscience, and beyond.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.